AQUIS STOCK EXCHANGE Aquis Stock Exchange: Notification of Apex constituent review
Transparency directive : regulatory news
|
Aquis Stock Exchange
AQSE announces the following changes to the Apex segment of the AQSE Growth Market following the bi-annual constituent review pursuant to Chapter 6 of the AQSE Growth Market Apex Rulebook. The changes are with effect from Monday, 20 June 2022:
Market value of securities The following issuers are to be transferred from the Apex segment to the Access segment as the average market value of the issuer’s securities for the three months prior to the first Friday of June 2021 was less than £10 million:
The Regulation Department Aquis Stock Exchange Level 2, 63 Queen Victoria Street London EC4N 4UA Tel: 0203 597 6361 Email: aqseregulation@aquis.eu Website: www.aquis.eu
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
1378577 17-Jun-2022